TODAY'S HEADLINES

First Zika test hits the market

Doctors are anxious to test for the Zika virus, particularly since the effects in infants are worse than previously believed. Read more

First drug approved for psychosis in Parkinson's

FDA approved the first drug to hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease. Read more

CONTINUING PHARMACY EDUCATION

The expanding role of direct oral anticoagulants in the management of thromboembolic disease

This month's CE activity is open for pharmacists and pharmacy technicians: "The expanding role of direct oral anticoagulants in the management of thromboembolic disease." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

FDA warns about Diflucan during pregnancy

Until FDA evaluates a new Danish study, FDA advises cautious prescribing of Diflucan in pregnancy. Read more

May 06, 2016

National Managed Care Pharmacy Survey 2016

Your input is needed! Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, is seeking your opinion on the current state of pharmacy. Take the survey and you could win a $200 Visa gift card. Answer Now.

Related Articles

Top 5 things to know about FDA's Zika blood guidelines

Study: Reduce long-term care use among patients with Parkinson's disease psychosis